681854-00-2

Basic information

• Product Name: 4H-Cyclopenta-1,3-dioxol-4-ol, 3a,6a-dihydro-2,2-diMethyl-4-[(triphenylMethoxy)Methyl]-, (3aS,4S,6aS)-
• Synonyms: 4H-Cyclopenta-1,3-dioxol-4-ol, 3a,6a-dihydro-2,2-diMethyl-4-[(triphenylMethoxy)Methyl]-, (3aS,4S,6aS)-;4H-Cyclopenta-1,3-dioxol-4-ol, 3a,6a-dihydro-2,2-diMethyl-4-[(triphenylMethoxy)Methyl]-, (3aS,4S,6aS)-6;(3aS,4S,6aS)-2,2-dimethyl-4-((trityloxy)methyl)-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-ol
• CAS NO: 681854-00-2
• Molecular Formula: C28H28O4
• Molecular Weight: 428.51952
• Mol File: 681854-00-2.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4H-Cyclopenta-1,3-dioxol-4-ol, 3a,6a-dihydro-2,2-diMethyl-4-[(triphenylMethoxy)Methyl]-, (3aS,4S,6aS)-(CAS DataBase Reference)
• NIST Chemistry Reference: 4H-Cyclopenta-1,3-dioxol-4-ol, 3a,6a-dihydro-2,2-diMethyl-4-[(triphenylMethoxy)Methyl]-, (3aS,4S,6aS)-(681854-00-2)
• EPA Substance Registry System: 4H-Cyclopenta-1,3-dioxol-4-ol, 3a,6a-dihydro-2,2-diMethyl-4-[(triphenylMethoxy)Methyl]-, (3aS,4S,6aS)-(681854-00-2)

Safety Data

• Hazardous Substances Data: 681854-00-2(Hazardous Substances Data)

Upstream product

• 54503-64-9 2,3-O-isopropylidene-5-O-trityl-D-ribofuranose 
• 67814-68-0 2,3-O-isopropylidene-D-ribofuranose 
• 50-69-1 D-ribose 
• 532-20-7 D-Ribose 
• 681853-96-3 (-)-1-[(4S,5S)-2,2-dimethyl-5-vinyl-1,3-dioxolan-4-yl]-2-(triphenylmethyloxy)ethan-1-one 
• 95666-80-1 (1R)-(-)-1-[(4R,5S)-2,2-dimethyl-5-vinyl-1,3-dioxolan-4-yl]-2-(triphenylmethyloxy)ethan-1-ol 
• 1779-49-3 Methyltriphenylphosphonium bromide 
• 902799-71-7 C₃₀H₃₂O₄ 
• 865838-12-6 (1R)-(-)-1-[(4S,5S)-2,2-dimethyl-5-vinyl-1,3-dioxolan-4-yl]-1-(triphenylmethyloxymethyl)-2-propen-1-ol 

Downstream Products

• 865838-26-2 RX-3117 

Relevant articles and documents

POLYMORPHIC COMPOUNDS AND USES THEREOF

The present invention provides compounds and methods of use thereof for treatment of certain disorders and conditions, for example brain injuries such as stroke or traumatic brain injuries.

Nucleoside derivatives and therapeutic uses therof

The present invention relates to nucleoside derivatives represented by general formulas I and II, their synthetic methods and their pharmacologically acceptable salts thereof, and compositions containing such compounds. Methods for treating hyperprolifera

Preparative and Stereoselective Synthesis of the Versatile Intermediate for Carbocyclic Nucleosides: Effects of the Bulky Protecting Groups to Enforce Facial Selectivity

The preparative and stereoselective synthesis (45-50% overall yields) of the target compound 17 has been accomplished from D-ribose. The bulky protecting groups such as TBDPS and Trityl enforced the facial selectivity during Grignard reaction to give the